A biocompatible superparamagnetic chitosan-based nanoplatform enabling targeted SN-38 delivery for colorectal cancer therapy

Carbohydr Polym. 2021 Nov 15:274:118641. doi: 10.1016/j.carbpol.2021.118641. Epub 2021 Sep 6.

Abstract

7-Ethyl-10-hydroxycamptothecin (SN-38) as a potent anti-tumor candidate, suffers the constraints from its poor water solubility, pH-dependent lactone ring stability and the lack of efficient delivery system without losing its activity. Herein, biocompatible superparamagnetic chitosan-based nanocomplexes complexing with water-soluble polymeric prodrug poly(L-glutamic acid)-SN-38 (PGA-SN-38) was engineered for efficient delivery of SN-38. The manufacturing process of colloidal complexes was green, expeditious and facile, with one-shot addition of PGA-SN-38 into chitosan solution without using any organic solvent or surfactant. Upon introducing ultra-small-size superparamagnetic nanoparticles (~10 nm), the developed magnetic nanocomplexes exhibited significantly boosted tumor-targeted accumulation and efficient cellular internalization under a local magnetic field. Notably, the magnetic nanocomplexes achieved distinctly superior targeting and anti-tumor efficacy in the established xenograft colorectal cancer model of mice, with high tumor suppression rate up to 81%. Therefore, this superparamagnetic chitosan-based nanocomplex system could provide a promising platform for the targeted delivery of SN-38 in colorectal cancer therapy.

Keywords: Colon cancer; Nanocomplexes; Polymeric prodrug; SN-38; Superparamagnetic nanoparticles.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Chitosan / chemistry*
  • Colorectal Neoplasms / drug therapy*
  • Drug Delivery Systems / methods*
  • HCT116 Cells
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Irinotecan / pharmacology*
  • Mice
  • Mice, Nude
  • Nanoparticles / chemistry*

Substances

  • Antineoplastic Agents
  • Irinotecan
  • Chitosan